287 related articles for article (PubMed ID: 34674120)
1. Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article.
Etaee F; Tobin M; Vuppala S; Komaki A; Delisle BP; Di Biase L; Catanzaro JN; Natale A; Elayi CS
J Interv Card Electrophysiol; 2022 Mar; 63(2):471-500. PubMed ID: 34674120
[TBL] [Abstract][Full Text] [Related]
2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
3. Opioids and Cardiac Arrhythmia: A Literature Review.
Behzadi M; Joukar S; Beik A
Med Princ Pract; 2018; 27(5):401-414. PubMed ID: 30071529
[TBL] [Abstract][Full Text] [Related]
4. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
[TBL] [Abstract][Full Text] [Related]
5. Assessing cardiac safety among clients receiving methadone as part of opioid agonist maintenance therapy (OAMT) in Durban, South Africa.
Prakaschandra DR; Scheibe A; Marks M; Naidoo DP
J Addict Dis; 2023; 41(1):82-90. PubMed ID: 35437125
[TBL] [Abstract][Full Text] [Related]
6. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
Isbister GK; Brown AL; Gill A; Scott AJ; Calver L; Dunlop AJ
Br J Clin Pharmacol; 2017 Oct; 83(10):2274-2282. PubMed ID: 28488266
[TBL] [Abstract][Full Text] [Related]
7. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
Ryan K; Benz P; Zosel A; Farkas A; Theobald J
Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
[TBL] [Abstract][Full Text] [Related]
8. QTc interval screening for cardiac risk in methadone treatment of opioid dependence.
Pani PP; Trogu E; Maremmani I; Pacini M
Cochrane Database Syst Rev; 2013 Jun; (6):CD008939. PubMed ID: 23787716
[TBL] [Abstract][Full Text] [Related]
9. Methadone-associated Q-T interval prolongation and torsades de pointes.
Stringer J; Welsh C; Tommasello A
Am J Health Syst Pharm; 2009 May; 66(9):825-33. PubMed ID: 19386945
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
Kao DP; Haigney MC; Mehler PS; Krantz MJ
Addiction; 2015 Sep; 110(9):1468-75. PubMed ID: 26075588
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
12. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.
Reddy S; Hui D; El Osta B; de la Cruz M; Walker P; Palmer JL; Bruera E
J Palliat Med; 2010 Jan; 13(1):33-8. PubMed ID: 19824814
[TBL] [Abstract][Full Text] [Related]
13. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
14. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
15. QTc prolongation in methadone maintenance--the role of HCV infection.
Gholami N; Boesch L; Falcato L; Stohler R; Bruggmann P
Swiss Med Wkly; 2013; 143():w13852. PubMed ID: 24018830
[TBL] [Abstract][Full Text] [Related]
16. Fluctuating QTc interval in an asymptomatic patient treated with methadone for chronic pain.
Ower K; Morley-Forster P; Moulin D
J Opioid Manag; 2005; 1(2):73-6. PubMed ID: 17319250
[TBL] [Abstract][Full Text] [Related]
17. Torsades de pointes with methadone.
Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
[TBL] [Abstract][Full Text] [Related]
18. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
19. Ventricular arrhythmias in patients treated with methadone for opioid dependence.
Hanon S; Seewald RM; Yang F; Schweitzer P; Rosman J
J Interv Card Electrophysiol; 2010 Jun; 28(1):19-22. PubMed ID: 20177760
[TBL] [Abstract][Full Text] [Related]
20. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
